Single-dose psilocybin therapy for alcohol use disorder: Pharmacokinetics, feasibility, safety and efficacy in an open-label study

Authors

Anders Fink‐Jensen (ORCID: https://orcid.org/0000-0001-7143-1236)
Nora D. Volkow (ORCID: https://orcid.org/0000-0001-6668-0908)
Dea Siggaard Stenbæk (ORCID: https://orcid.org/0000-0002-5439-4637)
Mathias E. Jensen (ORCID: https://orcid.org/0000-0002-2555-4785)
Sys Stybe Johansen (ORCID: https://orcid.org/0000-0002-9555-5134)
Gitte M. Knudsen (ORCID: https://orcid.org/0000-0003-1508-6866)
Patrick M. Fisher (ORCID: https://orcid.org/0000-0002-8115-0611)
Marie Katrine Klose Nielsen (ORCID: https://orcid.org/0000-0001-5159-8549)
Emil Deleuran Poulsen (ORCID: https://orcid.org/0009-0006-8165-2888)
Catharina Messell
Tibor V. Varga (ORCID: https://orcid.org/0000-0002-2383-699X)

Institutions

University of Copenhagen (DK)
Frederiksberg Hospital (DK)
Rigshospitalet (DK)
National Institute on Alcohol Abuse and Alcoholism (US)
Capital Region of Denmark (DK)

Publication Details

Journal: Journal of Psychopharmacology
Published: 2025-02-28
DOI: https://doi.org/10.1177/02698811251319457
Citations: 7
Primary Topic: Psychedelics and Drug Studies
Type: article
Field-Weighted Citation Impact: 16.15

Funders

Lundbeckfonden
Novo Nordisk
Helsefonden
Novo Nordisk Fonden
H. Lundbeck A/S

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Single-dose psilocybin therapy for alcohol use disorder: Pharmacokinetics, feasibility, safety and efficacy in an open-label study

Anders Fink‐Jensen, Nora D. Volkow, Dea Siggaard Stenbæk, Mathias E. Jensen et al.

Feb 28, 2025

7 citations

Journal of Psychopharmacology

Psychedelics and Drug Studies

16.15

article

Single-dose psilocybin therapy for alcohol use disorder: Pharmacokinetics, feasibility, safety and efficacy in an open-label study

Anders Fink‐Jensen, Nora D. Volkow, Dea Siggaard Stenbæk, Mathias E. Jensen, Sys Stybe Johansen, Gitte M. Knudsen, Patrick M. Fisher, Marie Katrine Klose Nielsen, Emil Deleuran Poulsen, Catharina Messell, Tibor V. Varga

February 28, 2025article en

7 citations

Abstract

No abstract available for this paper.

Journal of PsychopharmacologyVol. 39(5)

University of Copenhagen (DK), Frederiksberg Hospital (DK), Rigshospitalet (DK), National Institute on Alcohol Abuse and Alcoholism (US), Capital Region of Denmark (DK)

Lundbeckfonden, Novo Nordisk, Helsefonden, Novo Nordisk Fonden, H. Lundbeck A/S

Good health and well-being

Openalex Percentile: Top 1%

Psychedelics and Drug Studies

16.15

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Single-dose psilocybin therapy for alcohol use disorder: Pharmacokinetics, feasibility, safety and efficacy in an open-label study — Anders Fink‐Jensen, Nora D. Volkow, et al. · Journal of Psychopharmacology (2025) | TGRS Research Map | TGRS